158 related articles for article (PubMed ID: 18056057)
1. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.
Gramolini AO; Kislinger T; Alikhani-Koopaei R; Fong V; Thompson NJ; Isserlin R; Sharma P; Oudit GY; Trivieri MG; Fagan A; Kannan A; Higgins DG; Huedig H; Hess G; Arab S; Seidman JG; Seidman CE; Frey B; Perry M; Backx PH; Liu PP; MacLennan DH; Emili A
Mol Cell Proteomics; 2008 Mar; 7(3):519-33. PubMed ID: 18056057
[TBL] [Abstract][Full Text] [Related]
2. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy.
Kuzmanov U; Guo H; Buchsbaum D; Cosme J; Abbasi C; Isserlin R; Sharma P; Gramolini AO; Emili A
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12592-12597. PubMed ID: 27742792
[TBL] [Abstract][Full Text] [Related]
3. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
[TBL] [Abstract][Full Text] [Related]
4. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
Schmitt JP; Kamisago M; Asahi M; Li GH; Ahmad F; Mende U; Kranias EG; MacLennan DH; Seidman JG; Seidman CE
Science; 2003 Feb; 299(5611):1410-3. PubMed ID: 12610310
[TBL] [Abstract][Full Text] [Related]
5. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
[TBL] [Abstract][Full Text] [Related]
6. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
[TBL] [Abstract][Full Text] [Related]
7. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
[TBL] [Abstract][Full Text] [Related]
8. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
Minamisawa S; Hoshijima M; Chu G; Ward CA; Frank K; Gu Y; Martone ME; Wang Y; Ross J; Kranias EG; Giles WR; Chien KR
Cell; 1999 Oct; 99(3):313-22. PubMed ID: 10555147
[TBL] [Abstract][Full Text] [Related]
9. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
10. Insertional Mutagenesis Confounds the Mechanism of the Morbid Phenotype of a PLN
Kraev A
J Card Fail; 2018 Feb; 24(2):115-125. PubMed ID: 29325795
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.
Zhang D; Ezekiel UR; Chang SW; Zassenhaus HP
Cardiovasc Pathol; 2005; 14(2):61-9. PubMed ID: 15780797
[TBL] [Abstract][Full Text] [Related]
12. Impaired Ca2+-ATPase oligomerization and increased phospholamban expression in dilated cardiomyopathy.
Lennon NJ; O'Reilly C; Ohlendieck K
Int J Mol Med; 2000 Nov; 6(5):533-8. PubMed ID: 11029519
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
Schmidt AG; Zhai J; Carr AN; Gerst MJ; Lorenz JN; Pollesello P; Annila A; Hoit BD; Kranias EG
Cardiovasc Res; 2002 Nov; 56(2):248-59. PubMed ID: 12393095
[TBL] [Abstract][Full Text] [Related]
14. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.
Arai M; Alpert NR; MacLennan DH; Barton P; Periasamy M
Circ Res; 1993 Feb; 72(2):463-9. PubMed ID: 8418995
[TBL] [Abstract][Full Text] [Related]
15. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.
Haghighi K; Kolokathis F; Pater L; Lynch RA; Asahi M; Gramolini AO; Fan GC; Tsiapras D; Hahn HS; Adamopoulos S; Liggett SB; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
J Clin Invest; 2003 Mar; 111(6):869-76. PubMed ID: 12639993
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha.
Janczewski AM; Kadokami T; Lemster B; Frye CS; McTiernan CF; Feldman AM
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H960-9. PubMed ID: 12578819
[TBL] [Abstract][Full Text] [Related]
17. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
Kim HW; Ch YS; Lee HR; Park SY; Kim YH
Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
[TBL] [Abstract][Full Text] [Related]
18. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
19. Multiomics approach to identify novel biomarkers for dilated cardiomyopathy: Proteome and transcriptome analyses of 4C30 dilated cardiomyopathy mouse model.
Nishigori M; Yagi H; Mochiduki A; Minamino N
Biopolymers; 2016 Nov; 106(4):491-502. PubMed ID: 26799926
[TBL] [Abstract][Full Text] [Related]
20. Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death.
Yasuno S; Usami S; Kuwahara K; Nakanishi M; Arai Y; Kinoshita H; Nakagawa Y; Fujiwara M; Murakami M; Ueshima K; Harada M; Nakao K
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1804-10. PubMed ID: 19346456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
